LEXIVA (fosamprenavir) Patient Assistance Program
Don’t let the high cost of brand HIV protease inhibitor therapy disrupt your treatment. We help eligible patients access Lexiva (fosamprenavir) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Lexiva (fosamprenavir) is a HIV-1 protease inhibitor (PI) FDA-approved as a component of antiretroviral therapy in adults and pediatric patients (≥4 weeks). It is a prodrug of amprenavir, requiring boosting with ritonavir for adequate drug levels.
- Without assistance, Lexiva costs commonly run approximately $900–$1,200 per 30-day supply.
- Through AffordMyPrescriptions, qualifying patients can access Lexiva for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- Generic fosamprenavir is available in the U.S. at lower cost. HIV guidelines now generally prefer integrase-inhibitor-based regimens (Biktarvy, dolutegravir-based) for treatment-naïve patients. Boosted darunavir (Prezista, Prezcobix, Symtuza) is the preferred PI in current guidelines when a PI is needed.
What Is Lexiva Prescription Assistance Program?
The Lexiva Prescription Assistance Program is a manufacturer-sponsored initiative that provides Lexiva at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for HIV treatment patients who are uninsured or underinsured, as well as Medicare Part D beneficiaries.
Navigating the program on your own means dealing with eligibility verification, HIV provider coordination, prior-authorization documentation, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification.
Pharmacy Price Comparison
- Without assistance, brand Lexiva costs roughly $900–$1,200/month. Generic fosamprenavir is much cheaper. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens (brand) | ~$1,150.00 | Save ~$1,080/mo |
| CVS Pharmacy (brand) | ~$1,200.00 | Save ~$1,130/mo |
| Walmart (brand) | ~$1,000.00 | Save ~$930/mo |
| Costco (brand) | ~$950.00 | ~$950.00 |
Generic fosamprenavir | ~$400.00 | Generic — lower |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Lexiva Prescription Program?
The Patient Assistance Program is free to apply for and provides Lexiva at no medication cost if approved. Our $69.95/month service covers full advocacy. With generic fosamprenavir available — and modern INSTI-based regimens generally preferred — we’ll help you and your provider determine the best path.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Lexiva:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $900–$1,200 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Lexiva assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Lexiva Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Lexiva:
Lexiva (fosamprenavir) is an oral HIV-1 protease inhibitor used as a component of antiretroviral therapy. It is the prodrug of amprenavir and must be boosted with ritonavir for adequate antiviral activity. HIV guidelines now prefer integrase-inhibitor-based regimens for new starts; Lexiva is mostly historical except in patients already stable on it.
How Lexiva Works:
HIV-1 creates its essential proteins as a single large polyprotein, requiring a viral enzyme called protease to cut it into the individual functional pieces needed to form new infectious viruses. Fosamprenavir is converted within the body into active amprenavir, which binds directly to the HIV-1 protease and blocks this cutting process, resulting in non-infectious, immature virus particles instead. Because amprenavir is rapidly broken down by the liver enzyme CYP3A, it is co-administered with ritonavir, a CYP3A inhibitor. This combination safely boosts and maintains adequate drug levels in the body to allow for convenient once- or twice-daily dosing schedules.
Form and use:
Lexiva is available as oral tablets, which can be taken with or without food, and as an oral suspension, which must be taken on an empty stomach. The medication is typically taken alongside a ritonavir boost, with standard dosing tailored to a patient’s prior treatment history. For treatment-experienced patients, the typical regimen is 700 mg taken twice daily with 100 mg of ritonavir twice daily. For treatment-naïve patients, a once-daily dose of 1400 mg is used in combination with 100 mg to 200 mg of ritonavir once daily.
Generic availability:
Generic fosamprenavir is fully available in the United States at a significantly lower cost compared to the brand-name medication, Lexiva. Modern HIV clinical treatment guidelines generally favor alternative integrase-inhibitor-based regimens, such as Biktarvy or dolutegravir-based options, for patients who have never received treatment before. When a protease inhibitor is specifically required, healthcare providers typically prefer boosted darunavir options like Prezista with ritonavir, Prezcobix, or Symtuza. This preference is due to darunavir possessing a superior and higher genetic barrier to viral resistance compared to fosamprenavir.
Warnings:
Lexiva carries serious warnings for severe skin reactions like Stevens-Johnson syndrome, and because it contains a sulfa moiety, patients with known sulfa drug allergies may experience cross-reactivity. It can also cause liver toxicity, particularly in individuals co-infected with Hepatitis B or C, as well as metabolic changes like hyperglycemia, diabetes, hyperlipidemia, and fat redistribution. Additional risks include increased bleeding in hemophilia patients, kidney stones, and immune reconstitution syndrome. Furthermore, because amprenavir acts as both a substrate and inhibitor of CYP3A, ritonavir boosting significantly amplifies the risk of dangerous drug interactions.
FAQ (Frequently Asked Questions)
How Much Does Lexiva Cost Without Insurance?
Brand Lexiva costs approximately $900–$1,200 per 30-day supply. Generic fosamprenavir is substantially cheaper. Through AffordMyPrescriptions, qualifying patients receive Lexiva at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
Why Isn't Lexiva First-Line For New HIV Diagnoses?
HIV guidelines now prefer integrase-inhibitor-based regimens (Biktarvy, Triumeq, Dovato) as first-line therapy because they are once-daily single-tablet regimens with high resistance barriers, fewer drug interactions, and better long-term safety than PIs. When a PI is needed, boosted darunavir (Prezista) is preferred over fosamprenavir. Lexiva is mostly used in patients already stable on it or in specific resistance situations.
Why Does Lexiva Need Ritonavir Boosting?
Amprenavir (the active form of fosamprenavir) is broken down by liver CYP3A enzymes too quickly for adequate antiviral activity without help. Ritonavir is co-administered as a strong CYP3A inhibitor — it blocks amprenavir breakdown and keeps levels high enough for effective dosing. The ritonavir dose used for boosting (100–200 mg) is much lower than antiviral doses; ritonavir at boosting doses has no significant antiviral effect itself.
Can I Take Lexiva If I Have A Sulfa Allergy?
Fosamprenavir contains a sulfonamide moiety. Patients with sulfa allergy may have cross-reactivity. Tell your HIV provider about any sulfa allergy. Severe rash, including Stevens-Johnson syndrome, has been reported with Lexiva — any new rash should be evaluated promptly.
Are There Drug Interactions I Should Know About?
Yes — many. Amprenavir is a CYP3A substrate AND inhibitor, and ritonavir is a strong CYP3A inhibitor. This combination affects many other medications (statins, certain antifungals, antiarrhythmics, anticonvulsants, ergot alkaloids, and more). Some combinations are contraindicated. Always tell every prescriber and pharmacist that you take Lexiva with ritonavir.
Can I Get Lexiva Through The PAP If I Have Medicare?
Yes. Medicare Part D beneficiaries can typically qualify, especially if you face specialty-tier copays. State ADAP programs may also coordinate with Medicare for HIV-treatment patients.
What If My Application Is Denied?
If denied, we explore alternatives — switching to generic fosamprenavir, boosted darunavir (Prezista with generic ritonavir), or an integrase-inhibitor-based regimen (Biktarvy, Triumeq, Dovato), state ADAP, the manufacturer’s copay program for commercially insured patients, or independent foundations. If we cannot find a path, you won’t be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Lexiva, our team may be able to help you access assistance programs — or guide you to generic fosamprenavir or a more modern HIV regimen. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.